27.7 C
New York
Wednesday, June 10, 2026

Tag: union

Transaction in Own Shares

Transaction in Own Shares

Slovak Prime Minister Meets WeRide, Signals Support for Multi-Product Autonomous Vehicle Deployment

WeRide outlined plans to commercialize its L4 AV portfolio in Slovakia during a meeting with His Excellency Mr. Robert Fico Prime Minister of Slovakia.

ING rolls out global subscription banking model

ING rolls out global subscription banking model

Think Together Recognizes Jesse Durkin and Ricardo Molina with the 2026 Randy Barth Leadership Award

Peer-nominated award honors leaders who exemplify community impact and a commitment to changing the odds for kids across California.SANTA ANA, Calif., June 9, 2026...

CLINICIANS AT THREE OF WASHINGTON’S LARGEST HEALTHCARE SYSTEMS FILE TO UNIONIZE, CITING PATIENT CARE CONCERNS

SEATTLE, June 9, 2026 /PRNewswire/ -- Two hundred and fifty nurse practitioners and physician assistants working across multiple clinic locations at Fred Hutchinson Cancer...

TEAMSTERS-LED FASTER LABOR CONTRACTS ACT PASSES U.S. HOUSE WITH BIPARTISAN SUPPORT

Landmark Labor Law to Ensure Fair First Contracts for Workers Heads to U.S. SenateWASHINGTON, June 9, 2026 /PRNewswire/ -- With bipartisan support, the U.S....

FDA approves Lilly’s EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis

EBGLYSS is now the only approved option that offers as few as six maintenance injections per year with no required topicals from the startINDIANAPOLIS,...

MNA: Brigham Nurses to Hold Strike Authorization Vote as Mass General Brigham Contract Proposals Undermine Safe Patient Care and the BWH Nursing Workforce

MGB offers 0% cost of living raises and seeks to increase nurses' insurance costs despite being the wealthiest hospital system in MA and paying...

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

Transaction in Own Shares

Transaction in Own Shares

Duke-NUS awarded €2 million EU grant to help Asia detect outbreaks earlier through wastewater surveillance

EU-funded project will help countries build early-warning systems to spot infectious disease threats before clinical cases surge SINGAPORE, June 9, 2026 /PRNewswire/ -- Duke-NUS...

- A word from our sponsors -

spot_img
HomeTagsUnion